Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Vertex Spots Potential Bargain Of $60m Entry Into Complement Regulation
Cash-Strapped Catalyst Bio Forced Into Quick Sale
May 24 2022
•
By
Andrew McConaghie
Rights to the assets were handed back by Biogen in March, and have now been acquired in full by Vertex. • Source: Shutterstock
More from Deals
More from Business